AutoGenomics, Inc. · Carlsbad, CA United States
| 2251 Rutherford Rd. | Phone: 760-804-7378 |
| Carlsbad, CA | Fax: 760-804-7382 |
| 92008 | |
| United States |
AutoGenomics, Inc. Rankings
Company Description
AutoGenomics is mapping the road to the future of medicine. The company developed a genetic testing system called INFINITI that scans DNA samples for genetic disorders, infectious diseases, cancer, and pharmacogenetics (a patient's genetic likeliness to have an adverse reaction to a drug). AutoGenomics found about 25 uses for the INFINITI, but only four have been approved by the FDA for diagnostic use -- testing for sensitivity to the popular blood thinner warfarin, screening for the risk of developing cystic fibrosis or cervical cancer (for women with HPV), and testing for a gene that blocks common drugs from working. AutoGenomics was founded in 1999 as Neuron Technologies and applied to go public in 2008.
Financials
| Company Type | PrivateSingle Location |
|---|---|
| Fiscal Year-End | December |
| 2009 Employees | 100 |
Executives
16 executives listed for AutoGenomics, Inc.'s Carlsbad, CA location.
| Chairman, President, and CEO | Fareed Kureshy | |
|---|---|---|
| COO, CFO, Secretary, and Director | Thomas Hennessey | |
| Chief Scientific Officer | Nanibhushan Dattagupta |


